Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
39 hedge funds and large institutions have $134M invested in Axonics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
31.96% more ownership
Funds ownership: 0% → 31.96% (+32%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$24.6M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$19.1M |
| 3 |
RI
RTW Investments
New York
|
+$16.3M |
| 4 |
Millennium Management
New York
|
+$11.9M |
| 5 |
PA
Perceptive Advisors
New York
|
+$11.2M |
Top Sellers
AXNX Hedge Fund Activity: Q4 2018 in Review
39 of the 4,506 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q4 2018, worth a combined $134M.
Buyers outnumbered sellers: 39 funds opened new AXNX positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $24.6M.
- 39 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q4 2018, up from 0 in Q3 2018.
- Funds reported $134M of Axonics, Inc. Common Stock stock for Q4 2018.
- 39 funds opened new Axonics, Inc. Common Stock positions in Q4 2018 and 0 closed out, a net change of +39 holders.
- The largest Axonics, Inc. Common Stock buyer in Q4 2018 was Fidelity Investments, an estimated $24.6M added.
Based on aggregated 13F filings for Q4 2018.